Research Advances in Conjugated Polymer-Based Optical Sensor Arrays for Early Diagnosis of Clinical Diseases.
Early and accurate diagnosis is critical for disease surveillance, therapeutic guidance, and relapse monitoring.
APA
Ye Q, Fan S, et al. (2026). Research Advances in Conjugated Polymer-Based Optical Sensor Arrays for Early Diagnosis of Clinical Diseases.. Polymers, 18(3). https://doi.org/10.3390/polym18030310
MLA
Ye Q, et al.. "Research Advances in Conjugated Polymer-Based Optical Sensor Arrays for Early Diagnosis of Clinical Diseases.." Polymers, vol. 18, no. 3, 2026.
PMID
41682018
Abstract
Early and accurate diagnosis is critical for disease surveillance, therapeutic guidance, and relapse monitoring. Sensor arrays have emerged as a multi-analyte detection tool via non-specific interactions to generate unique fingerprint patterns with high levels of selectivity and discrimination. Conjugated polymers (CPs), with their tunable π-conjugated backbones, exceptional light-harvesting capability, and efficient "molecular wire effect," provide an ideal and versatile material platform for such arrays, enabling significant optical signal amplification and high sensitivity. This review systematically outlines the rational design and functionalization strategies of CPs for constructing high-performance sensor arrays. It delves into the structure-property relationships that govern their sensing performance, covering main-chain engineering, side-chain functionalization, and microenvironmental regulation. Representative applications are discussed, including non-small cell lung cancer, breast cancer, bacterial and viral infections, Alzheimer's disease, and diabetic nephropathy, highlighting the remarkable diagnostic capabilities achieved through tailored CP materials. Finally, future perspectives are focused on novel material designs and device integration to advance this vibrant field.
같은 제1저자의 인용 많은 논문 (5)
- Serum cytokine profiling identifies IL-17A and IL-10 as prognostic biomarkers for disease outcome in pediatric acute lymphoblastic leukemia.
- A new era in CAR-NK cell therapy: from technological innovations to clinical applications.
- Correlation of supportive proton pump inhibitor use during surgery with outcomes in patients with stage I-III colorectal cancer: A propensity score matching study.
- Nomogram for predicting postoperative recurrence in patients with microvascular invasion-negative hepatocellular carcinoma: development and validation.
- A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition.